List of bibliographic references indexed by Évaluation préclinique de médicament
Number of relevant bibliographic references: 41.
[0-20] [
0 - 20][
0 - 41][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000108 (2020) |
David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
| 000316 (2020) |
Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine] | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. |
| 000713 (2020) |
Shibo Jiang | Don't rush to deploy COVID-19 vaccines and drugs without sufficient safety guarantees. |
| 000C95 (2018) |
Rakhi Gawali [Inde] ; Jay Trivedi [Inde] ; Sujit Bhansali [Inde] ; Raghunath Bhosale [Inde] ; Dhiman Sarkar [Inde] ; Debashis Mitra [Inde] | Design, synthesis, docking studies and biological screening of 2-thiazolyl substituted -2,3-dihydro-1H-naphtho[1,2-e][1,3]oxazines as potent HIV-1 reverse transcriptase inhibitors. |
| 000D48 (2017) |
Wahiba Aouadi [France] ; Cécilia Eydoux [France] ; Bruno Coutard [France] ; Baptiste Martin [France] ; Françoise Debart [France] ; Jean Jacques Vasseur [France] ; Jean Marie Contreras [France] ; Christophe Morice [France] ; Gilles Quérat [France] ; Marie-Louise Jung [France] ; Bruno Canard [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France] | Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay |
| 000D81 (2017) |
Abdo A. Elfiky [Égypte] ; Samah M. Mahdy [Égypte] ; Wael M. Elshemey [Égypte] | Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses. |
| 000F59 (2016) |
Imke Steffen ; Graham Simmons [États-Unis] | Pseudotyping Viral Vectors With Emerging Virus Envelope Proteins. |
| 001269 (2015) |
Michael Berry [Afrique du Sud] ; Burtram C. Fielding [Afrique du Sud] ; Junaid Gamieldien [Afrique du Sud] | Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study. |
| 001634 (2014) |
Hatem A. Elshabrawy [États-Unis] ; Jilao Fan ; Christine S. Haddad ; Kiira Ratia ; Christopher C. Broder ; Michael Caffrey ; Bellur S. Prabhakar | Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay. |
| 001666 (2014) |
Ziwen Wang [République populaire de Chine] ; Anzheng Feng ; Mingbo Cui ; Yuxiu Liu ; Lizhong Wang ; Qingmin Wang | Design, synthesis, anti-tobacco mosaic virus (TMV) activity, and SARs of 7-methoxycryptopleurine derivatives. |
| 001693 (2014) |
Andy Kilianski [États-Unis] ; Susan C. Baker [États-Unis] | Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors. |
| 001702 (2014) |
Adeyemi O. Adedeji [États-Unis] ; Stefan G. Sarafianos [États-Unis] | Antiviral drugs specific for coronaviruses in preclinical development |
| 001876 (2013) |
Qi Zhao [États-Unis] ; Erin Weber ; Haitao Yang | Recent developments on coronavirus main protease/3C like protease inhibitors. |
| 001905 (2013) |
Adriaan H. De Wilde [Pays-Bas] ; V. Stalin Raj [Pays-Bas] ; Diede Oudshoorn [Pays-Bas] ; Theo M. Bestebroer [Pays-Bas] ; Stefan Van Nieuwkoop [Pays-Bas] ; Ronald W. A. L. Limpens [Pays-Bas] ; Clara C. Posthuma [Pays-Bas] ; Yvonne Van Der Meer [Pays-Bas] ; Montserrat Bárcena [Pays-Bas] ; Bart L. Haagmans [Pays-Bas] ; Eric J. Snijder [Pays-Bas] ; Bernadette G. Van Den Hoogen [Pays-Bas] | MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment |
| 001986 (2013) |
Andy Kilianski [États-Unis] ; Anna M. Mielech ; Xufang Deng ; Susan C. Baker | Assessing activity and inhibition of Middle East respiratory syndrome coronavirus papain-like and 3C-like proteases using luciferase-based biosensors. |
| 001A01 (2013) |
Guangyu Zhao [République populaire de Chine] ; Lanying Du ; Cuiqing Ma ; Ye Li ; Lin Li ; Vincent Km Poon ; Lili Wang ; Fei Yu ; Bo-Jian Zheng ; Shibo Jiang ; Yusen Zhou | A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. |
| 002093 (2011) |
Prasenjit Mukherjee ; Falgun Shah ; Prashant Desai ; Mitchell Avery | Inhibitors of SARS-3CLpro: Virtual Screening, Biological Evaluation and Molecular Dynamics Simulation Studies |
| 002104 (2011) |
So-Jung Park [Corée du Sud] ; Yang-Gyun Kim ; Hyun-Ju Park | Identification of RNA pseudoknot-binding ligand that inhibits the -1 ribosomal frameshifting of SARS-coronavirus by structure-based virtual screening. |
| 002370 (2011) |
Yanchen Zhou [États-Unis] ; Juliet Agudelo [États-Unis] ; Kai Lu [États-Unis] ; David H. Goetz [États-Unis] ; Elizabeth Hansell [États-Unis] ; Yen Ting Chen [États-Unis] ; William R. Roush [États-Unis] ; James Mckerrow [États-Unis] ; Charles S. Craik [États-Unis] ; Sean M. Amberg [États-Unis] ; Graham Simmons [États-Unis] | Inhibitors of SARS-CoV entry - Identification using an internally-controlled dual envelope pseudovirion assay |
| 002537 (2010) |
Hailong Yang [République populaire de Chine] ; Qiongqiong Zhou ; Bo Li ; Yongjian Wang ; Zhongzhi Luan ; Depei Qian ; Hanlu Li | GPU acceleration of Dock6's Amber scoring computation. |
| 002997 (2009) |
Christopher Mcguigan [Royaume-Uni] ; Mary Rose Kelleher ; Plinio Perrone ; Sinead Mulready ; Giovanna Luoni ; Felice Daverio ; Sonal Rajyaguru ; Sophie Le Pogam ; Isabel Najera ; Joseph A. Martin ; Klaus Klumpp ; David B. Smith | The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479). |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Évaluation préclinique de médicament"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i \
-Sk "Évaluation préclinique de médicament" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= MeshFr.i
|clé= Évaluation préclinique de médicament
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021 |  |
